Unique Techology
Our platform is designed to capture and detect disease-specific molecules at extremely low concentrations, enabling earlier and more reliable diagnosis than current standard methods.
ExoSphere is pioneering a new approach that combines advanced microfluidics
with highly sensitive biomarker detection technology.


Our platform is designed to capture and detect disease-specific molecules at extremely low concentrations, enabling earlier and more reliable diagnosis than current standard methods.

Unlike conventional technologies, our solution emphasizes speed, affordability, and scalability without compromising precision. This makes it suitable not only for cutting-edge research but also for widespread clinical use.

Our platform has broad applications across oncology diagnostics and beyond, including areas such as cardiovascular and infectious diseases. While the technology is versatile, our current focus is on breast, colorectal, and lung cancer—where early,(and) precise detection can have the greatest impact.
Contact us: contact@exosphere.bio